We report an unusual presentation of phaeochromocytoma in a young man with a painful, pulsatile abdominal mass and elevated blood pressures. This led to a delay in diagnosis and resulted in the administration of triggers of catecholamine release, possibly causing a catecholamine surge. This caused the development of catecholamineinduced cardiomyopathy and multiple organ failure, requiring inotropic and ventilatory support, intra-aortic balloon pump and dialysis. Fortunately, his condition reversed with supportive treatment and alpha-adrenergic blockade. This illustrates the importance of having a high index of suspicion of phaeochromocytoma, especially in young patients with elevated blood pressures.
Phaeochromocytoma is a rare endocrine tumour that classically presents with the triad of headache, palpitation and diaphoresis 1, 2 . It is associated with paroxysmal or sustained hypertension, and accounts for about 0.04% of all cases of hypertension 3 . Catecholamine-induced myocardial damage and acute pulmonary oedema are less widely recognized features of phaeochromocytoma 4 . Phaeochromocytoma is also a great mimic of diseases, and in 25 to 66% of cases is only diagnosed at autopsy [5] [6] [7] .
We report a case of phaeochromocytoma in a young man who presented unusually with elevated blood pressures and a painful pulsatile abdominal mass.
CASE REPORT
A 31-year-old man presented with a three-day history of worsening epigastric pain that radiated to his back. There was no history of trauma. He had no significant medical history, except for occasional headaches and palpitations that he attributed to stress. His initial blood pressure was 180/99 mmHg with a pulse rate of 56/min. A tender, firm, globular mass was palpable over the left hypochrondium, just below the subcostal margin. It measured 5 cm by 6 cm and was pulsatile. Although the attending physician felt that the pulsation was transmitted from the aorta, the patient was admitted with a provisional diagnosis of an abdominal aortic aneurysm. Empirical treatment of his raised blood pressure with oral nifedipine 5 mg reduced his blood pressure to 140/80 mmHg.
An urgent contrast-enhanced computerized tomography (CT) scan of the abdomen showed a soft tissue mass of 6 x 5 x 8 cm of heterogenous attenuation with a central hypodense area. It was closely related to the distal pancreatic body and tail, lateral to the abdominal aorta and anterior to the left psoas. The origin of the mass was uncertain, but it did not appear to be vascular. Both adrenals and kidneys were noted to be normal. The initial working diagnosis was that of a pancreatic cyst with possible bleeding into the cyst.
Four hours later, the patient complained of increasing abdominal pain, which was accompanied by central chest pain, causing him to vomit twice. He had a tachycardia of 141 beats/min and an elevated blood pressure of 140/100 mmHg. A 12-lead electrocardiogram showed sinus tachycardia. He was treated symptomatically with intramuscular pethidine 75 mg and metoclopramide 10 mg.
A further two hours later, his chest and abdominal pain had increased markedly in severity. He complained of breathlessness, and was tachypnoeic with a rate of 40 breaths/min. His blood pressure was 60/40 mmHg, and was accompanied by a heart rate of 140 beats/min. The jugular venous pressure was not raised and the heart sounds were normal, but there were coarse crackles throughout both lungs. The abdomen was soft and not guarded. He was given 1.5 litres of colloid intravenously with no improvement in blood pressure. He became cyanosed despite oxygen therapy, and was coughing frothy sputum.
His cardiac enzymes were not elevated, although his troponin T was positive. An urgent chest X-ray showed pulmonary oedema with upper lobe diversion and "bat-wings" appearance. The patient became unconscious, and cardiopulmonary resuscitation was initiated. On intubation, large amounts of frothy liquid came out of the endotracheal tube. Inotropic support with dobutamine (up to 45 µg/kg/min) and adrenaline (up to 0.15 µg/kg/min) was commenced. Bedside 2-D echocardiography of the heart showed severe global hypokinesia, with an ejection fraction of only 20%. An intra-aortic balloon pump (IABP) and pulmonary artery catheter were inserted to optimize haemodynamic management, and a blood pressure of 90/50 mmHg was achieved.
He developed acute respiratory distress syndrome (ARDS), requiring ventilatory support (Table 1) venous haemofiltration was initiated. The patient also developed a fever of 41°C, with elevated total white cell count (24,000/mm 3 with 91% polymorphs), thrombocytopenia, and positive disseminated intravascular coagulation markers. Although cultures were negative, empirical therapy with cefuroxime and vancomycin was started. He also developed acute hepatic failure with jaundice and raised blood ammonia levels. His investigation results were subsequently reviewed again. The clinical picture together with the CT scan results suggested that the patient had a paraganglioma (extra-adrenal phaeochromocytoma) arising from the left sympathetic chain, below the left renal artery. This was confirmed by the presence of raised urinary catecholamine levels ( Table 2) .
Therapy with phenoxybenzamine was commenced. By the fourth day of his intensive care unit (ICU) stay, the inotropic support and IABP had been successfully weaned off. A repeat 2D echo-cardiography showed that his ejection fraction had improved to 58%. His respiratory parameters improved progressively with his improved haemodynamics, and he was extubated on day 7 of ICU and discharged from ICU the next day.
He underwent excision of the phaeochromocytoma two weeks later. Anaesthesia and surgery were uneventful. A tumour measuring 8 cm x 7 cm x 5 cm weighing 100 g was excised, and was reported as a paraganglioma with extensive central necrosis within a rim of preserved peripheral tissue.
DISCUSSION
Phaeochromocytoma is a catecholamine-secreting tumour of chromaffin cells occurring in 1 to 2 per 100,000 adults per year 8 . First described by Frankel in 1886 9 and named by Pick in 1912, phaeochromocytomas usually arise in the adrenal medulla. Ten per cent of cases originate elsewhere: the sympathetic paravertebral plexus, organ of Zuckerkandl, or urinary bladder wall 10 .
Our patient first presented in the emergency room with abdominal pain, elevated blood pressure and a pulsatile abdominal mass, and was erroneously diagnosed as having an abdominal aortic aneurysm. Although uncommon, phaeochromocytomas can grow to large sizes 11, 12 . Most of these large tumours (>50 g and >8 cm in diameter) have been found incidentally 13 and even fewer were clinically palpable 14 . Phaeochromocytomas can also present with abdominal pain as the only symptom 15 . Various causes for the abdominal pain have been reported: spontaneous rupture 16, 17 , trauma 18 , bleeding into the tumour 19, 20 , ischaemic colitis 21 , release of vasoactive peptides 22 , or just a constitutional symptom 14 severe abdominal pain our patient experienced probably resulted from central necrosis of the tumour 14 .
Another factor contributing to the missed diagnosis was the ease with which his initial blood pressure was controlled by a small dose of calcium antagonist. This masked the importance of hypertension as a presenting sign. Hypertension, of sustained or paroxysmal nature, is an almost consistent manifestation of this disorder 23 . However, patients with tumours that secrete predominantly adrenaline, dopamine or other vasodilatory compounds can present with normal blood pressure or even hypotensive episodes 24 . The difficulty in diagnosis was compounded by not accurately presenting the clinical picture to the radiologists. With the right index of suspicion, the CT scan would have been suggestive of phaeochromocytoma. Instead, it was only discovered when the investigations were re-examined, leading to a delay in diagnosis.
This delay in diagnosis may have contributed to the stormy clinical course that followed. In known or suspected phaeochromocytoma patients, the use of oral or intravenous contrast is usually not required 23 . If contrast is required, prior adrenergic blockade is recommended as contrast can trigger a sudden catecholamine release 23 . An alternative would have been the use of magnetic resonance imaging (MRI) 25, 26 , or radio-labelled metaiodobenzylguanidine (MIBG) 26 . In the algorithm for investigation of an abdominal mass, the use of intravenous contrast with the CT scan in our patient was appropriate. Another consideration is that paroxysms of sudden release of catecholamines could be precipitated by drugs including opioids 27 and metoclopramide 28 . Because of the delay in diagnosis, the patient was given both of these.
The catecholamine release probably resulted in our patient developing catecholamine-induced cardiomyopathy. The pathogenesis of this cardiovascular injury is multifactorial. There is global reduction in myocardial pump function, secondary to downregulation of beta-receptors and a net reduction in viable myofibrils 29 . Alpha-adrenergic receptor mechanisms have also been suggested to account for the cardiomyopathies 30, 31 . High noradrenaline levels cause an alpha-receptor mediated decrease in coronary blood flow, which is aggravated by an increase in afterload. Excess noradrenaline also induces changes in permeability of the sarcolemmal membrane leading to increased calcium influx, giving rise to cellular necrosis 32, 33 . Oxidized products of catecholamines and free radicals may also contribute to the damage 34 . The catecholamine-induced cardiomyopathy was associated with multi-organ failure. Another con-tributory factor to multi-organ failure is believed to be a paraneoplastic syndrome 35 associated with phaeochromocytoma, in which pyrexia and elevation of acute phase proteins may be evident. It is thought that elaboration of interleukin-6 plays an important role in the development of this syndrome 36 .
Catecholamine-induced cardiomyopathy is sometimes reversible. As shown in our patient, aggressive haemodynamic support and the use of alphaadrenergic blockade was associated with recovery of the myocardium. The risks of administration of betaadrenergic blockade alone should be emphasized as this can lead to unopposed alpha-adrenergic effects with hypertensive crisis, worsening myocardial function and resultant pulmonary oedema 37 .
